Matches in SemOpenAlex for { <https://semopenalex.org/work/W2401683742> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W2401683742 endingPage "35" @default.
- W2401683742 startingPage "629" @default.
- W2401683742 abstract "Thalidomide, a sedative popular in the 1950s and withdrawn from the market in the 1960s because of its teratogenic effects, has emerged again on the market in the last decade as an effective agent in the treatment of multiple myeloma. Unfortunately, apart from positive treatment effects, numerous side effects have been shown in multiple myeloma patients, including drug-induced damage to peripheral nerves, leading to clinical neuropathy.A clinical and electrophysiological assessment of the prevalence of peripheral neuropathy in patients with multiple myeloma treated with thalidomide.The study included 43 patients (19 women and 24 men) with a clinical diagnosis of multiple myeloma and treated with thalidomide (average dose, 100 mg/d). Patients with a history of disorders or the presence of factors leading to nervous system damage were excluded from the study. An electrophysiological assessment of motor and sensory fibers of the median, ulnar, peroneal, and tibial nerves was performed.Polyneuropathy was present in 27 patients. In addition, carpal tunnel syndrome coexisting with polyneuropathy was observed in 6 patients. Carpal tunnel syndrome was reported in 4 patients. Moreover, supracondylar damage to the ulnar nerve was reported in 1 patient and Guyon syndrome--in 1 patient. The results of the electrophysiological study were normal in 10 patients.Our study showed that over 60% of patients treated with thalidomide have peripheral nerve changes typical for peripheral neuropathy. Owing to the high risk of peripheral neuropathy in patients treated with thalidomide, we recommend a routine electrophysiological study in all patients with multiple myeloma in order to diagnose neuropathy at an early stage. Dose reduction or the use of an equally effective but less neurotoxic drug allows to prevent polyneuropathy, while maintaining the basic parameters of cancer treatment." @default.
- W2401683742 created "2016-06-24" @default.
- W2401683742 creator A5035932093 @default.
- W2401683742 creator A5046942962 @default.
- W2401683742 creator A5087399449 @default.
- W2401683742 date "2015-01-01" @default.
- W2401683742 modified "2023-10-12" @default.
- W2401683742 title "[Thalidomide induced peripheral neuropathy in multiple myeloma patients]." @default.
- W2401683742 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27012121" @default.
- W2401683742 hasPublicationYear "2015" @default.
- W2401683742 type Work @default.
- W2401683742 sameAs 2401683742 @default.
- W2401683742 citedByCount "2" @default.
- W2401683742 countsByYear W24016837422021 @default.
- W2401683742 crossrefType "journal-article" @default.
- W2401683742 hasAuthorship W2401683742A5035932093 @default.
- W2401683742 hasAuthorship W2401683742A5046942962 @default.
- W2401683742 hasAuthorship W2401683742A5087399449 @default.
- W2401683742 hasConcept C126322002 @default.
- W2401683742 hasConcept C134018914 @default.
- W2401683742 hasConcept C141071460 @default.
- W2401683742 hasConcept C2775892965 @default.
- W2401683742 hasConcept C2776364478 @default.
- W2401683742 hasConcept C2779110535 @default.
- W2401683742 hasConcept C2779609412 @default.
- W2401683742 hasConcept C2779746960 @default.
- W2401683742 hasConcept C2779901536 @default.
- W2401683742 hasConcept C46762472 @default.
- W2401683742 hasConcept C555293320 @default.
- W2401683742 hasConcept C71924100 @default.
- W2401683742 hasConceptScore W2401683742C126322002 @default.
- W2401683742 hasConceptScore W2401683742C134018914 @default.
- W2401683742 hasConceptScore W2401683742C141071460 @default.
- W2401683742 hasConceptScore W2401683742C2775892965 @default.
- W2401683742 hasConceptScore W2401683742C2776364478 @default.
- W2401683742 hasConceptScore W2401683742C2779110535 @default.
- W2401683742 hasConceptScore W2401683742C2779609412 @default.
- W2401683742 hasConceptScore W2401683742C2779746960 @default.
- W2401683742 hasConceptScore W2401683742C2779901536 @default.
- W2401683742 hasConceptScore W2401683742C46762472 @default.
- W2401683742 hasConceptScore W2401683742C555293320 @default.
- W2401683742 hasConceptScore W2401683742C71924100 @default.
- W2401683742 hasIssue "11" @default.
- W2401683742 hasLocation W24016837421 @default.
- W2401683742 hasOpenAccess W2401683742 @default.
- W2401683742 hasPrimaryLocation W24016837421 @default.
- W2401683742 hasRelatedWork W106346935 @default.
- W2401683742 hasRelatedWork W1565406130 @default.
- W2401683742 hasRelatedWork W1971749062 @default.
- W2401683742 hasRelatedWork W1979270011 @default.
- W2401683742 hasRelatedWork W2044144069 @default.
- W2401683742 hasRelatedWork W2329856927 @default.
- W2401683742 hasRelatedWork W2401683742 @default.
- W2401683742 hasRelatedWork W2806060023 @default.
- W2401683742 hasRelatedWork W2876257590 @default.
- W2401683742 hasRelatedWork W2515107882 @default.
- W2401683742 hasVolume "72" @default.
- W2401683742 isParatext "false" @default.
- W2401683742 isRetracted "false" @default.
- W2401683742 magId "2401683742" @default.
- W2401683742 workType "article" @default.